Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.

Update on continued recovery efforts to mitigate shortages in Puerto Rico

Optum Workers' Comp
| Jan 05, 2018

The U.S. Food and Drug Administration (FDA) issued another update on the recovery efforts in Puerto Rico regarding the intravenous (IV) solution and medical device shortages that we have been following and providing updates about in our blogs. FDA Commissioner Scott Gottlieb stated that Baxter, a major supplier of intravenous saline and amino acids products, and all other facilities that manufacture products previously listed as critical and at risk of shortages, are back on the commercial power grid. As a result, many of these companies have reported to the FDA that their production levels are increasing and the shortage situation is expected to improve in the coming weeks.    

Although there are still shortages affecting patient care, the FDA will continue to monitor the situation and are confident that the facilities in Puerto Rico will return to being a vital and robust base for the manufacturing of these important medical products.

Please visit the FDA’s drug shortage website to obtain information on product availability.   

U.S. Food and Drug Administration. FDA Statement. Statement by FDA Commissioner Scott Gottlieb, M.D., update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages. January 4, 2018. Available at